Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rangering i aksjer #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Aksjekurs
$93.80
Sist synkronisert: 2025-04-28
Markedsverdi
$2.68B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Aerovate Therapeutics, Inc. (AVTE)

Kategori

Historikk for aksjesplitt for Aerovate Therapeutics, Inc. (AVTE)
Aksjen Aerovate Therapeutics, Inc. (symbol: AVTE) har gjennomgått totalt 1 aksjesplitt.
Den nyeste splittelsen skjedde Apr 29, 2025.
Én AVTE-aksje kjøpt før Apr 29, 2025 tilsvarer i dag 0.028571428571429 AVTE-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
2025-04-29 1:35 x0.028571428571429 x0.028571428571429
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH